Viral infections and asthma: an inflammatory interface?

Eur Respir J. 2014 Dec;44(6):1666-81. doi: 10.1183/09031936.00047714. Epub 2014 Sep 18.

Abstract

Asthma is a chronic inflammatory disease of the airways in which the majority of patients respond to treatment with corticosteroids and β₂-adrenoceptor agonists. Acute exacerbations of asthma substantially contribute to disease morbidity, mortality and healthcare costs, and are not restricted to patients who are not compliant with their treatment regimens. Given that respiratory viral infections are the principal cause of asthma exacerbations, this review article will explore the relationship between viral infections and asthma, and will put forward hypotheses as to why virus-induced exacerbations occur. Potential mechanisms that may explain why current therapeutics do not fully inhibit virus-induced exacerbations, for example, β₂-adrenergic desensitisation and corticosteroid insensitivity, are explored, as well as which aspects of virus-induced inflammation are likely to be attenuated by current therapy.

Publication types

  • Editorial
  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adrenergic beta-2 Receptor Agonists / therapeutic use
  • Anti-Inflammatory Agents / therapeutic use
  • Asthma / complications
  • Asthma / drug therapy
  • Asthma / immunology*
  • Bronchodilator Agents / therapeutic use
  • Disease Progression
  • Humans
  • Inflammation / immunology
  • Respiratory Tract Infections
  • Virus Diseases / complications
  • Virus Diseases / immunology*

Substances

  • Adrenal Cortex Hormones
  • Adrenergic beta-2 Receptor Agonists
  • Anti-Inflammatory Agents
  • Bronchodilator Agents